Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 4.2 First Supplemental Indenture - Penwest Pharmaceuticals Co.
- 4.3 Second Supplemental Indenture - Generics Bidco I, LLC
- 4.4 Third Supplemental Indenture - Ledgemont Royalty Sub LLC
- 4.5 Fourth Supplemental Indenture - Vintage Pharmaceuticals, LLC
- 4.6 Fifth Supplemental Indenture - American Medical Systems Holdings, Inc.
- 4.7 Sixth Supplemental Indenture - American Medical Systems, Inc.
- 4.8 Seventh Supplemental Indenture - Generics Bidco II, LLC
- 4.11 First Supplemental Indenture - American Medical Systems Holdings, Inc.
- 4.12 Second Supplemental Indenture - American Medical Systems, Inc.
- 4.13 Third Supplemental Indenture - Generics Bidco II, LLC
- 4.16 First Supplemental Indenture - American Medical Systems Holdings, Inc.
- 4.17 Second Supplemental Indenture - American Medical Systems, Inc.
- 4.18 Third Supplemental Indenture - Generics Bidco II, LLC
- 5 Opinion of Skadden, Arps, Slate, Meagher & Flom LLP
- 12 Statement Regarding Computation of Ratio of Earnings to Fixed Charges
- 21 Subsidiaries of the Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 23.2 Consent of Independent Registered Public Accounting Firm
- 23.3 Consent of Independent Registered Public Accounting Firm
- 25.1 Statement of Eligibility of Trustee, Indenture for 7.00% Senior Notes Due 2020
- 25.2 Statement of Eligibility of Trustee, Indenture for 7% Senior Notes Due 2019
- 25.3 Statement of Eligibility of Trustee, Indenture for 7 1/4% Senior Notes Due 2022
- 99.1 Form of Letter of Transmittal
- 99.2 Form of Letter to Clients
- 99.3 Form of Letter to Brokers
American Medical Systems similar filings
Filing view
External links